4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-049663
SVP & Chief Scientific Officer sold 1,701 shares at $19.32 ($32,863)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doberstein Stephen K SVP & Chief Scientific Officer | 2017-08-16 | Sale | −1,701 | $19.32 | $32,863 | 31,102 | D |
| Open-market sales · 1,701 sh · avg $19.32 · $32,863 | |||||||
Loading xslF345X03/doc4.xml…